Back to School: How biopharma can reboot drug development. Access exclusive analysis here

FDA backs off on supplements

WASHINGTON - Responding to public and political pressure, the FDA last week published a final rule on "structure/function" claims for dietary supplements that allows a broader range of claims than the agency originally proposed.

The

Read the full 347 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE